Advertisement
ALC vs DHR
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. Danaher Corporation (DHR) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC) operates in the specialized eye care sector with recent product innovations supporting revenue growth, while Danaher Corporation (DHR) spans life sciences and diagnostics with exposure to broader bioprocessing demand.
- In recent market activity, ALC has shown relatively stable performance with modest gains over the past month, contrasting with DHR’s sharper post-earnings volatility following softer-than-expected results in one segment.
- Both companies maintain strong balance sheets and recurring revenue elements, though DHR faces additional scrutiny around leadership transition and segment-specific growth consistency.
- Sector positioning differs markedly: ALC benefits from aging demographics and elective procedures in ophthalmology, whereas DHR’s diversified portfolio ties more closely to research and development spending cycles in life sciences.
- Market sentiment reflects ALC’s steadier momentum amid healthcare resilience, while DHR’s positioning highlights trade-offs between earnings beats and growth visibility concerns.
- Relative performance underscores contrasting risk profiles, with ALC offering narrower but more predictable exposure compared to DHR’s broader but cyclically sensitive operations.
Introduction
Alcon Inc. (ALC) and Danaher Corporation (DHR) represent distinct segments within the healthcare industry, making their comparison relevant for investors seeking exposure to medical devices and life sciences tools. ALC focuses on vision care products, while DHR provides a diversified platform across diagnostics, bioprocessing, and environmental solutions. Traders and portfolio managers evaluating sector allocation, relative momentum, or defensive healthcare positioning may find this analysis useful for understanding how each stock has navigated recent market conditions and operational developments.
ALC Overview and Recent Performance
Alcon Inc. (ALC) specializes in surgical and vision care products, including intraocular lenses and contact lenses, serving ophthalmology and optometry markets worldwide. In recent weeks, the stock has exhibited measured upward movement, supported by ongoing product launches and international expansion initiatives such as new collaboration centers. Broader market activity has reflected resilience in elective healthcare procedures despite macroeconomic pressures. Sentiment has been influenced by consistent quarterly results and innovation pipelines, contributing to steadier price behavior compared to more volatile healthcare peers.
DHR Overview and Recent Performance
Danaher Corporation (DHR) operates across life sciences, diagnostics, and environmental and applied solutions, with significant recurring revenue from instruments and consumables. Recent market activity has been marked by volatility following second-quarter results, where overall earnings exceeded expectations but bioprocessing sales came in softer than anticipated. A leadership transition has added layers to investor assessments. Performance in recent weeks shows recovery attempts after the initial reaction, with attention on growth visibility across its diversified segments amid fluctuating demand in research and development markets.
Trending AI Robots
Tickeron’s Trending AI Robots page curates select automated trading systems from hundreds of available AI trading bots that cover thousands of different tickers. Only those demonstrating strong alignment with prevailing market conditions earn inclusion in this focused section. The bots encompass a wide range of trading styles, strategies, timeframes, performance metrics, and ticker sets, allowing users to explore options suited to various risk tolerances and objectives. Factual statistics highlight varying win rates, profit factors, and drawdown profiles across the platform’s offerings. For further details on these AI-driven tools, visit the Trending AI Robots page.
Head-to-Head Comparison
Alcon Inc. (ALC) maintains a focused business model centered on eye care, driving growth through demographic trends and procedural volumes, whereas Danaher Corporation (DHR) leverages a broader platform with exposure to life sciences research spending and diagnostics. Recent momentum favors ALC’s narrower but steadier trajectory, while DHR contends with segment-specific softness and post-earnings adjustments. Risk factors for ALC include competitive pressures in vision products; DHR faces cyclical demand variability and integration risks from acquisitions. Sector exposure places ALC in medical devices with elective procedure sensitivity, contrasting DHR’s ties to capital equipment and consumables cycles. Market sentiment reflects ALC’s relative stability versus DHR’s emphasis on recovery potential following volatility.
Tickeron AI Verdict
Based on observable factors such as trend consistency and relative positioning in recent market activity, Tickeron’s AI would likely assign a probabilistic preference to Alcon Inc. (ALC) at present. ALC’s narrower focus has aligned with more stable performance amid healthcare resilience, while DHR’s broader exposure has encountered greater volatility tied to segment results and external variables. This assessment remains conditional on evolving data and does not constitute investment guidance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a StrongBuy and DHR is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 2 FA rating(s) are green whileDHR’s FA Score has 1 green FA rating(s).
- ALC’s FA Score: 2 green, 3 red.
- DHR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish while DHR’s TA Score has 6 bullish TA indicator(s).
- ALC’s TA Score: 4 bullish, 4 bearish.
- DHR’s TA Score: 6 bullish, 3 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а +5.72% price change this week, while DHR (@Medical Specialties) price change was +1.96% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.11%. For the same industry, the average monthly price growth was +8.49%, and the average quarterly price growth was +6.88%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +7.63%, and the average quarterly price growth was +23.29%.
Reported Earning Dates
ALC is expected to report earnings on Nov 10, 2026.
DHR is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.11% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-1.00% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| ALC | DHR | ALC / DHR | |
| Capitalization | 36.1B | 142B | 25% |
| EBITDA | 2.54B | 7.59B | 33% |
| Gain YTD | -6.712 | -10.559 | 64% |
| P/E Ratio | 56.68 | 36.09 | 157% |
| Revenue | 10.6B | 25.1B | 42% |
| Total Cash | 1.66B | 4.35B | 38% |
| Total Debt | 5.25B | 26.6B | 20% |
ALC | DHR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 32 Undervalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 92 | 100 | |
SMR RATING 1..100 | 88 | 79 | |
PRICE GROWTH RATING 1..100 | 51 | 48 | |
P/E GROWTH RATING 1..100 | 15 | 69 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (6) in the Medical Specialties industry is in the same range as ALC (32) in the Hospital Or Nursing Management industry. This means that DHR’s stock grew similarly to ALC’s over the last 12 months.
ALC's Profit vs Risk Rating (92) in the Hospital Or Nursing Management industry is in the same range as DHR (100) in the Medical Specialties industry. This means that ALC’s stock grew similarly to DHR’s over the last 12 months.
DHR's SMR Rating (79) in the Medical Specialties industry is in the same range as ALC (88) in the Hospital Or Nursing Management industry. This means that DHR’s stock grew similarly to ALC’s over the last 12 months.
DHR's Price Growth Rating (48) in the Medical Specialties industry is in the same range as ALC (51) in the Hospital Or Nursing Management industry. This means that DHR’s stock grew similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (15) in the Hospital Or Nursing Management industry is somewhat better than the same rating for DHR (69) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than DHR’s over the last 12 months.
| ALC | DHR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | 2 days ago 42% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 56% | 2 days ago 58% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 55% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 55% |
| Advances ODDS (%) | 4 days ago 57% | 8 days ago 54% |
| Declines ODDS (%) | 2 days ago 55% | 2 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 55% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 41% | 2 days ago 58% |
Advertisement
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
DHR and
Correlation & Price change
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To DHR | 1D Price Change % | ||
|---|---|---|---|---|
| DHR | 100% | -0.92% | ||
| TMO - DHR | 77% Closely correlated | -1.18% | ||
| A - DHR | 73% Closely correlated | +0.71% | ||
| RGEN - DHR | 68% Closely correlated | +1.08% | ||
| BIO - DHR | 64% Loosely correlated | -0.25% | ||
| BRKR - DHR | 58% Loosely correlated | -2.26% | ||
More | ||||